Rheumatology

Artificial intelligence in rheumatoid arthritis optimizes early diagnostic detection, image analysis, and targeted drug selection.

New real-world evidence shows that GLP-1 receptor agonists significantly reduce joint pain and inflammation in psoriatic arthritis.

Systemic autoimmune diseases significantly elevate the risk of developing cardiac arrhythmias and conduction disorders in patients.

Modified outcome definitions excluding corticosteroid metrics demonstrate that belimumab significantly improves lupus remission rates compared to placebo.

Biomaterial-based strategies for gout therapy offer targeted delivery options that improve drug bioavailability and local action.

Recent FDA approvals and newly accepted applications for obinutuzumab push lupus nephritis pregnancy management forward as new clinical guidelines reshape therapeutic safety choices.

Influenza and pneumococcal vaccination rates remain below recommended levels among patients with rheumatic diseases.

Scurvy can present with hemarthrosis and musculoskeletal symptoms that closely mimic inflammatory rheumatologic disease.